Magnesium in PDB 7pf1: Uvc Treated Human Apoferritin
Other elements in 7pf1:
The structure of Uvc Treated Human Apoferritin also contains other interesting chemical elements:
Magnesium Binding Sites:
Pages:
>>> Page 1 <<<
Page 2, Binding sites: 11 -
20;
Page 3, Binding sites: 21 -
30;
Page 4, Binding sites: 31 -
40;
Page 5, Binding sites: 41 -
50;
Page 6, Binding sites: 51 -
60;
Page 7, Binding sites: 61 -
70;
Page 8, Binding sites: 71 -
80;
Page 9, Binding sites: 81 -
90;
Page 10, Binding sites: 91 -
100;
Page 11, Binding sites: 101 -
110;
Page 12, Binding sites: 111 -
120;
Page 13, Binding sites: 121 -
130;
Page 14, Binding sites: 131 -
140;
Page 15, Binding sites: 141 -
150;
Page 16, Binding sites: 151 -
160;
Page 17, Binding sites: 161 -
167;
Binding sites:
The binding sites of Magnesium atom in the Uvc Treated Human Apoferritin
(pdb code 7pf1). This binding sites where shown within
5.0 Angstroms radius around Magnesium atom.
In total 167 binding sites of Magnesium where determined in the
Uvc Treated Human Apoferritin, PDB code: 7pf1:
Jump to Magnesium binding site number:
1;
2;
3;
4;
5;
6;
7;
8;
9;
10;
Magnesium binding site 1 out
of 167 in 7pf1
Go back to
Magnesium Binding Sites List in 7pf1
Magnesium binding site 1 out
of 167 in the Uvc Treated Human Apoferritin
![](/pictures/MG/pdb/pf/7pf1-MG-sphere_01.jpg) Mono view
![](/pictures/MG/pdb/pf/7pf1-MG-sphere_01_stereo.jpg) Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 1 of Uvc Treated Human Apoferritin within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Mg205
b:20.1
occ:1.00
|
O
|
J:HOH549
|
1.9
|
30.6
|
1.0
|
O
|
A:HOH587
|
2.0
|
23.7
|
1.0
|
O
|
J:HOH385
|
2.0
|
16.5
|
1.0
|
O
|
A:HOH340
|
2.1
|
23.7
|
1.0
|
O
|
J:HOH444
|
2.1
|
20.5
|
1.0
|
O
|
A:HOH374
|
2.3
|
20.1
|
1.0
|
OD2
|
A:ASP134
|
4.0
|
25.2
|
1.0
|
O
|
J:THR138
|
4.2
|
21.5
|
1.0
|
O
|
A:HOH583
|
4.3
|
50.9
|
1.0
|
CG2
|
A:THR138
|
4.4
|
24.1
|
1.0
|
O
|
J:HOH490
|
4.4
|
23.6
|
1.0
|
OD1
|
A:ASP134
|
4.5
|
24.6
|
1.0
|
OG1
|
A:THR138
|
4.5
|
24.0
|
1.0
|
CA
|
J:THR138
|
4.6
|
16.6
|
1.0
|
CG
|
A:ASP134
|
4.7
|
18.6
|
1.0
|
O
|
A:HOH504
|
4.7
|
34.1
|
1.0
|
O
|
J:GLU137
|
4.8
|
20.3
|
1.0
|
C
|
J:THR138
|
4.8
|
18.9
|
1.0
|
CB
|
A:THR138
|
5.0
|
20.1
|
1.0
|
O
|
J:HOH471
|
5.0
|
14.0
|
1.0
|
|
Magnesium binding site 2 out
of 167 in 7pf1
Go back to
Magnesium Binding Sites List in 7pf1
Magnesium binding site 2 out
of 167 in the Uvc Treated Human Apoferritin
![](/pictures/MG/pdb/pf/7pf1-MG-sphere_02.jpg) Mono view
![](/pictures/MG/pdb/pf/7pf1-MG-sphere_02_stereo.jpg) Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 2 of Uvc Treated Human Apoferritin within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Mg206
b:24.0
occ:1.00
|
SG
|
A:CYS105
|
2.0
|
16.3
|
1.0
|
O
|
A:HOH547
|
2.2
|
35.8
|
1.0
|
CB
|
A:CYS105
|
3.0
|
15.1
|
1.0
|
O
|
A:HOH454
|
3.3
|
39.6
|
1.0
|
CA
|
A:CYS105
|
3.6
|
15.8
|
1.0
|
O
|
A:HOH542
|
3.7
|
27.4
|
1.0
|
O
|
A:HOH418
|
4.2
|
29.8
|
1.0
|
N
|
A:CYS105
|
4.4
|
14.1
|
1.0
|
O
|
A:HOH316
|
4.4
|
40.0
|
1.0
|
CZ3
|
A:TRP96
|
4.5
|
19.8
|
1.0
|
SG
|
A:CYS93
|
4.7
|
19.2
|
1.0
|
C
|
A:CYS105
|
4.8
|
14.9
|
1.0
|
O
|
A:CYS105
|
5.0
|
16.1
|
1.0
|
|
Magnesium binding site 3 out
of 167 in 7pf1
Go back to
Magnesium Binding Sites List in 7pf1
Magnesium binding site 3 out
of 167 in the Uvc Treated Human Apoferritin
![](/pictures/MG/pdb/pf/7pf1-MG-sphere_03.jpg) Mono view
![](/pictures/MG/pdb/pf/7pf1-MG-sphere_03_stereo.jpg) Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 3 of Uvc Treated Human Apoferritin within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Mg207
b:56.3
occ:1.00
|
O
|
T:HOH554
|
2.1
|
41.8
|
1.0
|
OD1
|
A:ASP45
|
2.4
|
17.0
|
1.0
|
O
|
A:HOH373
|
2.7
|
22.9
|
1.0
|
O
|
A:HOH389
|
3.1
|
30.1
|
1.0
|
NZ
|
T:LYS149
|
3.4
|
14.6
|
1.0
|
CG
|
A:ASP45
|
3.6
|
16.0
|
1.0
|
O
|
T:HOH334
|
3.8
|
38.5
|
1.0
|
O
|
T:HOH396
|
3.9
|
24.8
|
1.0
|
OD2
|
T:ASP153
|
3.9
|
14.4
|
1.0
|
O
|
A:HOH393
|
3.9
|
19.1
|
1.0
|
O
|
A:ASP45
|
4.1
|
13.5
|
1.0
|
O
|
A:HOH343
|
4.3
|
13.9
|
1.0
|
O
|
A:HOH563
|
4.3
|
51.6
|
1.0
|
OD2
|
A:ASP45
|
4.4
|
15.2
|
1.0
|
CB
|
A:ASP45
|
4.5
|
14.5
|
1.0
|
CA
|
A:ASP45
|
4.6
|
14.3
|
1.0
|
CE
|
T:LYS149
|
4.6
|
13.9
|
1.0
|
C
|
A:ASP45
|
4.8
|
14.4
|
1.0
|
CG
|
T:ASP153
|
4.9
|
15.3
|
1.0
|
|
Magnesium binding site 4 out
of 167 in 7pf1
Go back to
Magnesium Binding Sites List in 7pf1
Magnesium binding site 4 out
of 167 in the Uvc Treated Human Apoferritin
![](/pictures/MG/pdb/pf/7pf1-MG-sphere_04.jpg) Mono view
![](/pictures/MG/pdb/pf/7pf1-MG-sphere_04_stereo.jpg) Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 4 of Uvc Treated Human Apoferritin within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Mg208
b:25.9
occ:1.00
|
O
|
A:HOH341
|
1.8
|
21.4
|
1.0
|
OE1
|
A:GLU64
|
2.0
|
22.4
|
1.0
|
OE1
|
A:GLN61
|
2.2
|
38.9
|
1.0
|
O
|
A:HOH399
|
2.4
|
33.5
|
1.0
|
O
|
A:HOH349
|
2.5
|
21.9
|
1.0
|
CD
|
A:GLU64
|
3.3
|
21.6
|
1.0
|
CD
|
A:GLN61
|
3.3
|
28.3
|
1.0
|
O
|
A:HOH434
|
3.5
|
53.0
|
1.0
|
O
|
A:HOH380
|
3.5
|
49.0
|
1.0
|
NE2
|
A:GLN61
|
4.0
|
36.5
|
1.0
|
OE2
|
A:GLU64
|
4.1
|
25.0
|
1.0
|
CB
|
A:GLU64
|
4.2
|
18.5
|
1.0
|
CG
|
A:GLU64
|
4.3
|
20.3
|
1.0
|
O
|
A:HOH301
|
4.4
|
29.3
|
1.0
|
O
|
A:HOH449
|
4.4
|
40.3
|
1.0
|
OE2
|
A:GLU110
|
4.4
|
37.8
|
1.0
|
OE2
|
A:GLU65
|
4.5
|
32.5
|
1.0
|
CG
|
A:GLN61
|
4.5
|
23.1
|
1.0
|
CB
|
A:ALA147
|
4.5
|
16.5
|
1.0
|
O
|
A:HOH464
|
4.6
|
33.5
|
1.0
|
CA
|
A:GLN61
|
4.6
|
16.4
|
1.0
|
OE1
|
A:GLU143
|
4.6
|
35.8
|
1.0
|
CB
|
A:GLN61
|
4.7
|
18.4
|
1.0
|
CD
|
A:GLU143
|
4.7
|
31.6
|
1.0
|
O
|
A:GLN61
|
4.9
|
17.2
|
1.0
|
OE2
|
A:GLU143
|
4.9
|
37.2
|
1.0
|
CE1
|
A:HIS68
|
5.0
|
35.1
|
1.0
|
|
Magnesium binding site 5 out
of 167 in 7pf1
Go back to
Magnesium Binding Sites List in 7pf1
Magnesium binding site 5 out
of 167 in the Uvc Treated Human Apoferritin
![](/pictures/MG/pdb/pf/7pf1-MG-sphere_05.jpg) Mono view
![](/pictures/MG/pdb/pf/7pf1-MG-sphere_05_stereo.jpg) Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 5 of Uvc Treated Human Apoferritin within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Mg209
b:19.2
occ:1.00
|
OE1
|
A:GLU30
|
1.9
|
19.3
|
1.0
|
OE1
|
A:GLU65
|
2.0
|
24.4
|
1.0
|
O
|
A:HOH330
|
2.1
|
14.1
|
1.0
|
ND1
|
A:HIS68
|
2.1
|
28.3
|
1.0
|
O
|
A:HOH322
|
2.2
|
23.4
|
1.0
|
O
|
A:HOH303
|
2.3
|
57.2
|
1.0
|
CE1
|
A:HIS68
|
3.0
|
35.1
|
1.0
|
CD
|
A:GLU30
|
3.0
|
16.9
|
1.0
|
CD
|
A:GLU65
|
3.0
|
26.9
|
1.0
|
CG
|
A:HIS68
|
3.3
|
25.7
|
1.0
|
OE2
|
A:GLU30
|
3.3
|
19.8
|
1.0
|
OE2
|
A:GLU65
|
3.4
|
32.5
|
1.0
|
CB
|
A:HIS68
|
3.7
|
18.6
|
1.0
|
O
|
A:HOH394
|
4.1
|
30.5
|
1.0
|
OE1
|
A:GLN144
|
4.1
|
26.4
|
1.0
|
NE2
|
A:HIS68
|
4.2
|
38.0
|
1.0
|
CG
|
A:GLU30
|
4.3
|
15.5
|
1.0
|
CG1
|
A:VAL113
|
4.3
|
18.4
|
1.0
|
CD2
|
A:HIS68
|
4.3
|
31.5
|
1.0
|
O
|
A:HOH312
|
4.3
|
57.0
|
1.0
|
CG
|
A:GLU65
|
4.4
|
20.2
|
1.0
|
CA
|
A:GLU65
|
4.6
|
15.2
|
1.0
|
CB
|
A:GLU30
|
4.7
|
14.9
|
1.0
|
CB
|
A:GLU65
|
4.7
|
17.0
|
1.0
|
O
|
A:HOH434
|
4.7
|
53.0
|
1.0
|
CA
|
A:GLU30
|
4.9
|
14.3
|
1.0
|
CD
|
A:GLN144
|
4.9
|
20.6
|
1.0
|
OE1
|
A:GLU110
|
4.9
|
31.7
|
1.0
|
|
Magnesium binding site 6 out
of 167 in 7pf1
Go back to
Magnesium Binding Sites List in 7pf1
Magnesium binding site 6 out
of 167 in the Uvc Treated Human Apoferritin
![](/pictures/MG/pdb/pf/7pf1-MG-sphere_06.jpg) Mono view
![](/pictures/MG/pdb/pf/7pf1-MG-sphere_06_stereo.jpg) Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 6 of Uvc Treated Human Apoferritin within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Mg210
b:51.7
occ:1.00
|
O
|
A:HOH315
|
1.9
|
29.2
|
1.0
|
O
|
A:HOH540
|
2.1
|
37.2
|
1.0
|
O
|
A:HOH375
|
2.1
|
18.2
|
1.0
|
O
|
A:HOH521
|
2.4
|
37.5
|
1.0
|
O
|
A:HOH598
|
2.4
|
42.7
|
1.0
|
O
|
A:HOH604
|
2.5
|
48.2
|
1.0
|
OD1
|
A:ASN28
|
4.1
|
13.8
|
1.0
|
O
|
A:ARG25
|
4.3
|
13.2
|
1.0
|
O
|
A:HOH537
|
4.3
|
29.1
|
1.0
|
O
|
A:HOH600
|
4.3
|
49.7
|
1.0
|
O
|
A:HOH567
|
4.4
|
19.0
|
1.0
|
O
|
A:HOH348
|
4.6
|
25.9
|
1.0
|
O
|
A:HOH582
|
4.7
|
9.8
|
1.0
|
CB
|
A:LEU29
|
4.7
|
13.5
|
1.0
|
CB
|
A:ASN28
|
4.8
|
13.5
|
1.0
|
CG
|
A:ASN28
|
4.8
|
14.2
|
1.0
|
N
|
A:LEU29
|
4.8
|
12.7
|
1.0
|
O
|
A:HOH565
|
5.0
|
44.2
|
1.0
|
CD1
|
A:LEU29
|
5.0
|
16.9
|
1.0
|
CA
|
A:LEU29
|
5.0
|
13.2
|
1.0
|
|
Magnesium binding site 7 out
of 167 in 7pf1
Go back to
Magnesium Binding Sites List in 7pf1
Magnesium binding site 7 out
of 167 in the Uvc Treated Human Apoferritin
![](/pictures/MG/pdb/pf/7pf1-MG-sphere_07.jpg) Mono view
![](/pictures/MG/pdb/pf/7pf1-MG-sphere_07_stereo.jpg) Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 7 of Uvc Treated Human Apoferritin within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Mg212
b:56.3
occ:1.00
|
O
|
A:HOH556
|
2.1
|
41.8
|
1.0
|
OD1
|
O:ASP45
|
2.4
|
17.0
|
1.0
|
O
|
O:HOH373
|
2.7
|
22.9
|
1.0
|
O
|
O:HOH389
|
3.1
|
30.1
|
1.0
|
NZ
|
A:LYS149
|
3.4
|
14.6
|
1.0
|
CG
|
O:ASP45
|
3.6
|
16.0
|
1.0
|
O
|
A:HOH334
|
3.8
|
38.5
|
1.0
|
O
|
A:HOH397
|
3.9
|
24.8
|
1.0
|
OD2
|
A:ASP153
|
3.9
|
14.4
|
1.0
|
O
|
O:HOH393
|
3.9
|
19.1
|
1.0
|
O
|
O:ASP45
|
4.1
|
13.5
|
1.0
|
O
|
O:HOH343
|
4.3
|
13.9
|
1.0
|
O
|
O:HOH563
|
4.3
|
51.6
|
1.0
|
OD2
|
O:ASP45
|
4.4
|
15.2
|
1.0
|
CB
|
O:ASP45
|
4.5
|
14.5
|
1.0
|
CA
|
O:ASP45
|
4.6
|
14.3
|
1.0
|
CE
|
A:LYS149
|
4.6
|
13.9
|
1.0
|
C
|
O:ASP45
|
4.8
|
14.4
|
1.0
|
CG
|
A:ASP153
|
4.9
|
15.3
|
1.0
|
|
Magnesium binding site 8 out
of 167 in 7pf1
Go back to
Magnesium Binding Sites List in 7pf1
Magnesium binding site 8 out
of 167 in the Uvc Treated Human Apoferritin
![](/pictures/MG/pdb/pf/7pf1-MG-sphere_08.jpg) Mono view
![](/pictures/MG/pdb/pf/7pf1-MG-sphere_08_stereo.jpg) Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 8 of Uvc Treated Human Apoferritin within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Mg213
b:19.2
occ:1.00
|
O
|
A:HOH317
|
2.0
|
17.2
|
1.0
|
O
|
W:HOH593
|
2.1
|
18.3
|
1.0
|
O
|
W:HOH530
|
2.2
|
20.0
|
1.0
|
O
|
A:HOH308
|
2.2
|
18.4
|
1.0
|
O
|
W:HOH362
|
4.1
|
16.6
|
1.0
|
OD2
|
A:ASP87
|
4.1
|
15.0
|
1.0
|
OD1
|
A:ASP87
|
4.1
|
14.4
|
1.0
|
O
|
W:HOH448
|
4.4
|
49.7
|
1.0
|
CG
|
A:ASP87
|
4.5
|
15.4
|
1.0
|
O
|
W:HOH591
|
4.5
|
23.6
|
1.0
|
NZ
|
W:LYS89
|
4.7
|
13.9
|
1.0
|
CL
|
A:CL204
|
4.7
|
26.5
|
1.0
|
O
|
W:HOH524
|
4.8
|
34.7
|
1.0
|
CE
|
W:LYS90
|
4.8
|
29.6
|
1.0
|
|
Magnesium binding site 9 out
of 167 in 7pf1
Go back to
Magnesium Binding Sites List in 7pf1
Magnesium binding site 9 out
of 167 in the Uvc Treated Human Apoferritin
![](/pictures/MG/pdb/pf/7pf1-MG-sphere_09.jpg) Mono view
![](/pictures/MG/pdb/pf/7pf1-MG-sphere_09_stereo.jpg) Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 9 of Uvc Treated Human Apoferritin within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Mg205
b:20.1
occ:1.00
|
O
|
R:HOH545
|
1.9
|
30.6
|
1.0
|
O
|
B:HOH585
|
2.0
|
23.7
|
1.0
|
O
|
R:HOH386
|
2.0
|
16.5
|
1.0
|
O
|
B:HOH340
|
2.1
|
23.7
|
1.0
|
O
|
R:HOH444
|
2.1
|
20.5
|
1.0
|
O
|
B:HOH374
|
2.3
|
20.1
|
1.0
|
OD2
|
B:ASP134
|
4.0
|
25.2
|
1.0
|
O
|
R:THR138
|
4.2
|
21.5
|
1.0
|
O
|
B:HOH580
|
4.3
|
50.9
|
1.0
|
CG2
|
B:THR138
|
4.4
|
24.1
|
1.0
|
O
|
R:HOH488
|
4.4
|
23.6
|
1.0
|
OD1
|
B:ASP134
|
4.5
|
24.6
|
1.0
|
OG1
|
B:THR138
|
4.5
|
24.0
|
1.0
|
CA
|
R:THR138
|
4.6
|
16.6
|
1.0
|
CG
|
B:ASP134
|
4.7
|
18.6
|
1.0
|
O
|
B:HOH505
|
4.7
|
34.1
|
1.0
|
O
|
R:GLU137
|
4.8
|
20.3
|
1.0
|
C
|
R:THR138
|
4.8
|
18.9
|
1.0
|
O
|
R:HOH469
|
5.0
|
14.0
|
1.0
|
CB
|
B:THR138
|
5.0
|
20.1
|
1.0
|
|
Magnesium binding site 10 out
of 167 in 7pf1
Go back to
Magnesium Binding Sites List in 7pf1
Magnesium binding site 10 out
of 167 in the Uvc Treated Human Apoferritin
![](/pictures/MG/pdb/pf/7pf1-MG-sphere_10.jpg) Mono view
![](/pictures/MG/pdb/pf/7pf1-MG-sphere_10_stereo.jpg) Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 10 of Uvc Treated Human Apoferritin within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Mg206
b:24.0
occ:1.00
|
SG
|
B:CYS105
|
2.0
|
16.3
|
1.0
|
O
|
B:HOH546
|
2.2
|
35.8
|
1.0
|
CB
|
B:CYS105
|
3.0
|
15.1
|
1.0
|
O
|
B:HOH454
|
3.3
|
39.6
|
1.0
|
CA
|
B:CYS105
|
3.6
|
15.8
|
1.0
|
O
|
B:HOH541
|
3.7
|
27.4
|
1.0
|
O
|
B:HOH419
|
4.2
|
29.8
|
1.0
|
N
|
B:CYS105
|
4.4
|
14.1
|
1.0
|
O
|
B:HOH316
|
4.4
|
40.0
|
1.0
|
CZ3
|
B:TRP96
|
4.5
|
19.8
|
1.0
|
SG
|
B:CYS93
|
4.7
|
19.2
|
1.0
|
C
|
B:CYS105
|
4.8
|
14.9
|
1.0
|
O
|
B:CYS105
|
5.0
|
16.1
|
1.0
|
|
Reference:
J.S.Depelteau,
L.Renault,
N.Althof,
C.K.Cassidy,
L.M.Mendonca,
G.J.Jensen,
G.P.Resch,
A.Briegel.
Uvc Inactivation of Pathogenic Samples Suitable For Cryo-Em Analysis. Commun Biol V. 5 29 2022.
ISSN: ESSN 2399-3642
PubMed: 35017666
DOI: 10.1038/S42003-021-02962-W
Page generated: Thu Oct 3 04:09:55 2024
|